Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000946333 | SCV000532664 | likely benign | not provided | 2019-01-17 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000444315 | SCV000615114 | benign | not specified | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001498371 | SCV001703121 | likely benign | Hyperkalemic periodic paralysis | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002480320 | SCV002797467 | likely benign | Hypokalemic periodic paralysis, type 1; Potassium-aggravated myotonia; Paramyotonia congenita of Von Eulenburg; Hypokalemic periodic paralysis, type 2; Hyperkalemic periodic paralysis; Congenital myasthenic syndrome 16 | 2021-10-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004539892 | SCV004761980 | likely benign | SCN4A-related disorder | 2020-03-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |